The first comprehensive
telemedical CTG solution
for fetal health monitoring
Nothing can replace the experience and knowledge of professional medical staff.
Pregnabit is a telemedical device, designed to support the work of doctors and
midwives. It enables CTG monitoring of pregnant women at any time and anywhere.
Nestmedic’s CEO has been awarded „Innovator Of The Year 2016” by MIT Technology Review.
Telecom’s technology accelerator Orange Fab has awarded Nestmedic with distinction in Poland.
New Europe 100 — changemakers in Central and Eastern Europe. Res Publica, Google, Visegrad Fund and Financial Times selected 100 innovation leaders from CEE region. Our CEO, Patrycja Wizińska-Socha is on this list.
Distinction for „the most innovative product at the fair” by the organizer of International Healthcare Exhibition held in Warsaw (WIHE).
Pregnabit among the winners of GO_GLOBAL.PL competition organized by the National Centre for Research and Development. In the recent edition GO_GLOBAL.PL experts evaluated 80 applications for funding. The most innovative companies won, the ones planning to commercialize their solutions in world markets.
Nearly 60 years ago, in 1957 Orvan Hess and Edward Hon developed the first device for continuous monitoring of the heart rate of the fetus. Since then, CTG equipment has undergone a number of upgrades. Time has come for a breakthrough. Pregnabit combines well-known and proven features of professional stationary CTG device, which is used in hospitals worldwide, with the features of modern mobile devices.
Pregnabit is a medical device and, like stationary CTG – is not available for sale to patients.
Pregnabit will be available for international sale in 2017. We invite everyone interested in scientific and commercial cooperation. We will be pleased to tell you about the potential of this fast growing telemedicine segment and launch assumptions of Pregnabit® platform.
Pregnabit manufacturer just received CE certification and ISO 13485, enabling sales of the product in the European Union. In December, the company will start selling its solution in an innovative, subscription based model. Will offer diagnostic services KTG addressed to gynecologists and midwives. Taking into account the development of the global market of telemedicine, NestmedicPregnabit manufacturer just received CE certification and ISO 13485, enabling sales of the product
Nestmedic, as one of six innovative Polish companies presented Pregnabit device during a ceremonial signing of the new law on innovation in the Presidential Palace. The Act provides, among others, abolition of income tax on intellectual property brought into the company, from 1 January 2017. The new regulations provide a tax deduction for the costNestmedic, as one of six innovative Polish companies presented Pregnabit device during a ceremonial
Nestmedic CEO was recognized by Res Publica Foundation, the International Visegrad Fund, Google and the newspaper “Financial Times”, which placed our CEO on the list of “New Europe 100” – a hundred people who set standards for innovation in Central and Eastern Europe. The Financial Times wrote about “third annual list of the best andNestmedic CEO was recognized by Res Publica Foundation, the International Visegrad Fund, Google and